Literature DB >> 25755609

Risk factors for hepatocellular carcinoma in India.

Premashis Kar1.   

Abstract

Hepatocellular carcinoma (HCC) is an important cause of death all over the world, more so in Asia and Africa. The representative data on epidemiology of HCC in India is very scanty and cancer is not a reportable disease in India and the cancer registries in India are mostly urban. 45 million people who are suffering from chronic Hepatitis B virus (HBV) infection and approximately 15 million people who are afflicted with chronic Hepatitis C virus (HCV) infection in India. HBV and HCV infection is considered an important etiologic factor in HCC. Positive association between HCC and consumption of alcohol where alcohol contribute as a cofactor for hepatotoxins and hepatitis viruses. Aflatoxin contamination in the diets, Hepatitis B virus infection and liver cirrhosis in Andhra Pradesh, India and direct chronic exposure to aflatoxins was shown to cause liver cirrhosis. Cirrhosis of liver of any cause lead to develop about 70%-90% of HCC. Aflatoxin interact synergistically with Hepatitis B virus (HBV)/Hepatitis C virus (HCV) infection which increase the risk of HCC. HBV infection, HBV infection with Aflatoxin exposure, viral infection and alcohol consumption leading to overt cirrhosis of the liver, alcohol consumption leading to cirrhosis of the liver with viral infection are the predominant risk factor for the development of HCC. HCV and alcohol are also associated with HCC in India. Indians develop diabetes at younger age, Asians have strong genetic susceptibility for type II diabetes. Diabetes mellitus is identified as a risk factor for HCC. Prevention of viral infection by universal vaccination against hepatitis virus, HCC surveillance program, preventing alcoholic liver diseases, fungal contamination of grains and ground crops to prevent basically Aflatoxin exposure are important measures to prevent liver diseases and HCC among those at risk.

Entities:  

Keywords:  AFB1, aflatoxin B1; DM, diabetes mellitus; GT, glucose tolerance; HBV, Hepatitis B virus; HBsAg, hepatitis-B surface antigen; HCC; HCC, hepatocellular carcinoma; HCV, Hepatitis C virus; IARC, International Agency for Research on Cancer; NAFLD, non-alcoholic fatty liver disease; RR, relative risk; aflatoxin; risk factor

Year:  2014        PMID: 25755609      PMCID: PMC4284237          DOI: 10.1016/j.jceh.2014.02.155

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  78 in total

1.  Impact of medical recommendations on alcohol consumption in HCV positive patients.

Authors:  B Nalpas; S Martin; H Fontaine; P Fabbro-Peray; C Bréchot; S Pol
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

Review 2.  Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.

Authors:  C Bréchot; M Minami; S De Mitri; P Paterlini
Journal:  Princess Takamatsu Symp       Date:  1995

Review 3.  Aflatoxins.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1993

4.  Nonalcoholic steatohepatitis: clinicopathological profile.

Authors:  D N Amarapurkar; A D Amarapurkar
Journal:  J Assoc Physicians India       Date:  2000-03

5.  Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.

Authors:  S K Sarin; V Thakur; R C Guptan; S Saigal; V Malhotra; S P Thyagarajan; B C Das
Journal:  J Gastroenterol Hepatol       Date:  2001-06       Impact factor: 4.029

6.  Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes.

Authors:  Perumal Vivekanandan; Michael Torbenson; Banumathi Ramakrishna
Journal:  J Gastrointest Cancer       Date:  2011-03

7.  Hepatitis-B x-antigen in the pathogenesis of hepatocellular-carcinoma (review).

Authors:  M Feitelson
Journal:  Oncol Rep       Date:  1995-03       Impact factor: 3.906

8.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease.

Authors:  H Tsukuma; T Hiyama; S Tanaka; M Nakao; T Yabuuchi; T Kitamura; K Nakanishi; I Fujimoto; A Inoue; H Yamazaki
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

9.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

10.  Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma?

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

View more
  13 in total

Review 1.  A Review on Dietary and Non-Dietary Risk Factors Associated with Gastrointestinal Cancer.

Authors:  Lohith Mysuru Shivanna; Asna Urooj
Journal:  J Gastrointest Cancer       Date:  2016-09

2.  Differential expression of angiogenesis-related miRNAs and VEGFA in cirrhosis and hepatocellular carcinoma.

Authors:  André R C P de Oliveira; Márcia M U Castanhole-Nunes; Patrícia M Biselli-Chicote; Érika C Pavarino; Rita de C M A da Silva; Renato F da Silva; Eny M Goloni-Bertollo
Journal:  Arch Med Sci       Date:  2020-08-10       Impact factor: 3.318

3.  Studied microRNA gene expression in human hepatocellular carcinoma by microRNA microarray techniques.

Authors:  Jian-Xiang Niu; Xing-Kai Meng; Jian-Jun Ren
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

4.  ARA lncRNA, is upregulated in liver and breast tumor tissues.

Authors:  Farzaneh Raeisi; Mahdieh Abolfathi; Raheleh Ahmadi-Naji; Sara Iranparast; Esmat Noshadi; Arvand Akbari; Esmaeil Mahmoudi; Mansoor Khaledi; Asghar Arshi
Journal:  Mol Biol Rep       Date:  2018-10-26       Impact factor: 2.316

Review 5.  Should We Treat Immune Tolerant Chronic Hepatitis B? Lessons from Asia.

Authors:  Madhumita Premkumar; Yogesh K Chawla
Journal:  J Clin Exp Hepatol       Date:  2021-08-27

Review 6.  Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation.

Authors:  Juanjuan Gu; Min Yao; Dengbing Yao; Li Wang; Xuli Yang; Dengfu Yao
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

Review 7.  Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses.

Authors:  Deborah A Boyle
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Apr-Jun

8.  Hepatitis C virus load in parenchyma cells correlates with hepatic injury in infected patients.

Authors:  Zhen Xu; Ji-Zong Lin; Guo-Li Lin; Fang-Fang Wei; Jing Liu; Zhi-Xin Zhao; Ying Zhang; Wei-Ming Ke; Xiao-Hong Zhang
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

9.  Evaluation of liver function and electroacupuncture efficacy of animals with alcoholic liver injury by the novel imaging methods.

Authors:  Dong Zhang; Xiao-Jing Song; Shun-Yue Li; Shu-You Wang; Bing-Jun Chen; Xiao-Dong Bai; Li-Mei Tang
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

Review 10.  Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.

Authors:  Aakash Desai; Sonia Sandhu; Jin-Ping Lai; Dalbir Singh Sandhu
Journal:  World J Hepatol       Date:  2019-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.